Key Insights

Highlights

No notable highlights available yet

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 3 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

2Total
Not Applicable (1)
P 2 (1)

Trial Status

Recruiting2
Not Yet Recruiting1

Clinical Trials (3)

Showing 3 of 3 trials
NCT06790147Not Yet RecruitingPrimary

Stenting for Ischemic Strokes Secondary to Medically Refractory Intracranial Atherosclerotic Disease

NCT04948749Not ApplicableRecruitingPrimary

Drug Eluting Stenting and Aggressive Medical Treatment for Preventing Recurrent Stroke in Intracranial Atherosclerotic Disease Trial

NCT05503225Phase 2RecruitingPrimary

Colchicine Use in Intracranial Atherosclerotic Disease

Showing all 3 trials

Research Network

Activity Timeline